This meeting of the International Association for the Study of Lung Cancer is designed to provide information about ongoing clinical trials of the newest therapies for lung cancer. The meeting presenters summarize the data on relevant targets for new therapies. Data on preclinical and early clinical data are presented for each of the drugs directed against these targets. The meeting also presents data on early predictive biomarkers. There are also presentations from fellows and young investigators in training and debates about controversial topics. The meeting is a unique resource for clinical investigators, including those in academia, clinical practice and industry.